Aditxt, Inc. Net Assets
Aditxt, Inc. (ADTX) had Net Assets of $266.45 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Consolidation and Presentation of Financial Statements
us-gaap:AssetsNet · last filed 2025-03-31
- 2024-12-31: Net Assets $266.45K.
- 2024-09-30: Net Assets $266.45K.
- 2024-06-30: Net Assets $266.45K.
| Period end | Net Assets |
|---|---|
| 2024-12-31 | $266.45K 10-K · filed 2025-03-31 |
| 2024-09-30 | $266.45K 10-Q · filed 2024-11-18 |
| 2024-06-30 | $266.45K 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |